ID   ZEC-061
AC   CVCL_VT82
DR   CCRID; 4201PAT-CCTCC00893
DR   Wikidata; Q98136458
RX   Patent=CN106222142A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201692.
CC   Population: Chinese.
CC   Doubling time: ~48 hours (Patent=CN106222142A).
ST   Source(s): Patent=CN106222142A
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D12S391: 20,22
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D6S1043: 19
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 14,16
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106222142A;
RA   Su D., Mao W.-M., Liu J.-S., Ying L.-S., Wu J.-Z.;
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106222142A, 14-Dec-2016.
//